DL Chemical subsidiary starts operations at Singapore plant, largest manufacturer of surgical glove materials - South Korean report

DL Chemical, a petrochemical company in the DL Group (formerly the Obayashi Group), has announced that its subsidiary Cariflex, a manufacturer and seller of synthetic rubber, has begun operations at its Singapore plant.
Cariflex, which DL Chemical acquired for 620 billion won ($681.99 billion) in 2020, produces synthetic rubber and latex using the Minus Eon catalyst.
It is the largest manufacturer of polyisoprene surgical glove materials. The company's products are not only hypoallergenic, but also contain fewer impurities and are more transparent than those of other companies. It offers a wide range of high-value-added products, from surgical gloves to rubber stoppers for syringes.
The company's polyisoprene latex is gaining popularity as a material for medical devices, and the quality and safety of the material has been recognized, leading to growing demand.
To stay ahead of growing market demand, DL Chemical is building a 480 billion won (approximately 52.799 billion yen) new facility in an industrial park on Singapore's Jurong Island.
The company invested in a new polyisoprene plant for Cariflex. The new plant will be the largest in the world, covering an area of 61,000 square meters. It is located in Southeast Asia, where the factories of the company's major customers are concentrated.
The company has an advantage in ensuring smooth product supply, and is also seen as being well-positioned to create synergies with existing research facilities in Malaysia.